TITLE

INVESTMENT BANKING DATABASE: HEALTHCARE

PUB. DATE
February 2005
SOURCE
Investment Dealers' Digest;2/28/2005, Vol. 71 Issue 8, p40
SOURCE TYPE
Trade Publication
DOC. TYPE
Article
ABSTRACT
The article presents information on the recent developments related to investment banking in the healthcare sector. Carl Icahn, who owns a 9.8% stake in Mylan Laboratories Inc., sued the genetic drug maker to block recently amended corporate bylaws announced by the company calling for director nominations within 10 days. A dozen women have filed a class-action lawsuit against Swiss-based drug maker Novartis AG, claiming gender discrimination. Some of the issuers and bookrunners listed are Morgan Stanley & Co. Inc., UBS AG, Citigroup and J.P. Morgan Chase.
ACCESSION #
16262879

 

Related Articles

  • Morgan Stanley set to pay $1.25bn over US mortgage lawsuit. Morris, Pamela // Fundweb;2/5/2014, p20 

    The article focuses on the settlement made by the investment bank Morgan Stanley and Co. Inc. for a lawsuit over the sale of faulty mortgage bonds. It states that the bank is paying 1.25 billion dollar over the claims of faulty mortgage bonds sales to Fannie Mae and Freddie Mac mortgage...

  • IDD OutTakes.  // Investment Dealers' Digest;7/25/2005, Vol. 71 Issue 29, p6 

    The article presents news related to the U.S. investment industry. Morgan Stanley & Co. Inc.'s newly appointed chief executive officer (CEO), John Mack is courting four former Morgan Stanley executives, Joseph Perella, Terry Meguid, Vikram Pandit and John Havens to try to get them to return....

  • Indonesia: Bankers play long game as Indonesia slows. Ferguson, Nick // FinanceAsia;Aug2013, p1 

    The article issues raised by slow economic growth, rising inflation and weak currency for the investment banking sector across the globe and mentions that after the China's stopping of initial public offerings, investment banks are looking forward to Southeast Asian countries for business...

  • Banks on the Hook for Parmalat Demise.  // Investment Dealers' Digest;6/18/2007, Vol. 73 Issue 24, p9 

    The article discusses that Citigroup Inc., UBS AG, Deutsche Bank AG and Morgan Stanley &3x0026; Co. Inc. were accused of failing to impose procedures that would have stopped crimes that led to the demise of Italian food company Parmalat USA Corp. It states that the suit could ultimately lead to...

  • Health Care REIT, Inc. Announces Proposed Offering of 11,000,000 Shares of Common Stock.  // Biomedical Market Newsletter;8/7/2012, Vol. 21, p1 

    The article informs that Health Care REIT Inc. will offer 11,000,000 shares of its common stock subjected to market and other conditions. It also informs about joint book-running managers for the offering including the company BofA Merrill Lynch, Morgan Stanley & Co. Inc. and UBS Investment...

  • LVMH, Morgan Stanley Back in Court. Marsh, Emilie; Socha, Miles // WWD: Women's Wear Daily;3/31/2006, Vol. 191 Issue 68, p2 

    This article reports that LVMH Moët Hennessy Louis Vuitton and Morgan Stanley will present their cases in the appeals court in Paris, France on March 31, 2006 in connection with LVMH's bias suit against the investment bank. Previously, al court ordered Morgan Stanley to pay LVMH 30 million...

  • Obama Plan Could Cost 5 Banks $13B.  // American Banker;1/25/2010, Vol. 175 Issue 12, p12 

    This article reports that analysts at the financial services firm JPMorgan Chase & Co. have estimated that the plan of U.S. President Barack Obama to curb proprietary trading would cost five banks a total of thirteen billion dollars. The banks that would be affected are listed as Goldman Sachs...

  • Health Care REIT Inc. Completes $811 Mln Common Stock Offering.  // Biomedical Market Newsletter;8/15/2012, Vol. 21, p1 

    The article presents information on an announcement made by Health Care REIT Inc. regarding the completion of its public offering of 13,800,000 shares of common stock at a price of 58.75 U.S. dollars per share. The joint book-running managers for the offering were Morgan Stanley & Co. Inc., UBS...

  • Health Care REIT Inc. Announces Pricing of 6.50% Series J Cumulative Redeemable Preferred Stock.  // Biomedical Market Newsletter;3/7/2012, Vol. 21, p1 

    The article informs that Health Care REIT Inc. has released the pricing of its public offering of 6.50 percent Series J Cumulative Redeemable Preferred Stock. It mentions the joint book-running managers for the offering which includes UBS Investment Bank, Wells Fargo Securities LLC and Morgan...

Share

Read the Article

Courtesy of VIRGINIA BEACH PUBLIC LIBRARY AND SYSTEM

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics